Nuclear Medicine Research
The Division of Nuclear Medicine is actively involved in several research initiatives to improve patient care and health outcomes. The team is participating in national and international clinical trials and investigator-initiated studies. A primary focus of our Nuclear Medicine research is Theranostics, which is the combination of using the same radiolabeled biological molecule radiolabeled with specific radionuclides for both diagnosis and treatment.
Our division has the latest Nuclear Medicine imaging technology available, including digital SPECT/CT, digital PET/CT, and PET/MR. In addition, in collaboration with Philips Healthcare, we are evaluating a novel digital PET/CT (Vereos) using Ga-68 PSMA in prostate lesions in men with rising PSA before biopsy, in prostate cancer patients with bone metastases, and patients with brain tumors.
We also support important research initiatives throughout University Hospitals and Case Western Reserve University as Authorized Users for unsealed sources in the area of neurodegenerative diseases, including Alzheimer's and Parkinson's Diseases, cardiac perfusion and metabolism, and oncology.
The faculty of the Nuclear Medicine Division are members of the Case Center for Imaging Research and Case Comprehensive Cancer Center. In addition, our faculty members have mentored several medical students at Case Western Reserve University School of Medicine and have been successful in publishing research articles in leading journals. We have a tradition of fostering interdisciplinary and multi-institutional collaboration and look forward to furthering the University Hospitals' mission of advancing medical research.
Research Team
- Norbert Avril, MD
- Arash Kardan, MD
- Zhenghong Lee, PhD
- Raymond F. Muzic, Jr., PhD
- Yanming Wang, PhD